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Abstract 
Moulds may produce a diversity of toxins such as aflatoxins, ochratoxins, 
trichothecenes, zearalenone, fumonisins and others. Although toxicological, 
environmental and epidemiological studies have addressed the problem of these 
toxins one by one, more than one mycotoxin are found usually in the same 
contaminated food. Risk assessment for humans potentially exposed to multi-
mycotoxins suffers very much from the lack of adequate food consumption data. 
Furthermore, for a given mycotoxin, synergism and antagonism with other 
mycotoxins, found in the same food commodities, are not taken into account.  
     Aflatoxin B1 and ochratoxin A belong to the most frequently occurring 
mycotoxins. This has repeatedly been demonstrated, however, normally, the risk 
resulting from their simultaneous occurrence is not considered.  
     A descriptive study was developed to monitor air fungal contamination in one 
hospital food unit. Five air samples of 250 litres through impaction method were 
collected in food storage facilities, kitchen, food plating, canteen and also, 
outside premises, since this is the place regarded as reference.  
     Besides other species, Aspergillus flavus and Aspergillus ochraceus were 
isolated in the studied food unit. It was used weight-of-evidence scheme 
proposed by Mumtaz and Durkin to qualitative assess the weight of evidence for 
the toxicological interaction between Aflatoxin B1 and ochratoxin A.  
     In this case, risk assessment must be performed considering the toxicological 
interactions between these two mycotoxins. The limits for mycotoxins human 
exposure only consider the effects of each toxin and do not take into 
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consideration their combined effects. Moreover, the study was developed in a 
setting where must be considered the sensibility of exposed population. 
Keywords: exposure to mycotoxins, food contamination, multi-mycotoxins 
exposure, toxicological interactions, risk assessment. 
1 Introduction 
Assessing the toxicity and health risk of environmental chemicals is a complex 
process. Moreover, is well established that people are exposed to a diverse and 
dynamic mixture of environmental stressors as a routine part of their existence, 
and there is clear evidence that toxicity can be modified by simultaneous or 
sequential exposure to multiple environmental agents [1–3].  
     A major challenge in risk assessment is to determine the degree of exposure 
to multiple chemicals, the hazards associated with such combined exposure and 
the extent to which chemicals interact. Such interactions may result in effects 
that are either antagonistic or synergistic [4]. Risk assessments have, 
nevertheless, focused mainly on the narrow question of harm from exposure to 
individual chemicals in a specific environmental medium via a single route or 
pathway [5].  
     Chemical constituents of a mixture do not necessarily have similar properties; 
the composition is not necessarily constant; and the mixture may occur 
frequently, occasionally, or rarely. Moreover, the strength of interactive effects 
may differ as a function of the components doses depending on any non 
linearities in the dose–response relation for the biological processes affected by 
the components. A further complication is that the temporal characteristics of 
both exposures and resulting alterations in biological processes may differ for 
different components of coincidental mixtures [5]. 
     Additionally, in an attempt to extrapolate from the high doses in animal 
studies to the lower levels to which humans are exposed, a wide range of models 
from simple linear extrapolation to very complex ones have been developed and 
used [6]. 
As a result, mixtures risk assessments usually involve substantial uncertainties. If 
the mixture is treated as a single complex substance, these doubts range from 
inexact descriptions of exposure to inadequate toxicity information. When 
viewed as a simple collection of a few component chemicals, the uncertainties 
include the generally poor understanding of the magnitude and nature of 
toxicological interactions, especially those interactions involving three or more 
chemicals. Because of these difficulties, the assessment of health risk from 
chemical mixtures must include a thorough discussion of all assumptions and the 
identification when possible of the major sources of uncertainty. 
     Based on the work developed by Mumtaz and Durkin [7] it was defined 
Weight-of-Evidence (WOE) classification, a judgment reflecting the quality of 
the available information that categorizes the most plausible nature of any 
potential influence of one compound on the toxicity of another compound, for a 
given exposure scenario. This methodology not focuses specifically on the types 
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of data available to support a WOE determination, but on the interpretation of 
the data made by an analyst or a group of analysts [7, 8].  
     The scheme is based on the assessment of the direction of an interaction, the 
plausibility that the interaction will occur, and the potential relevance of the 
interaction to human health. 
     Accordingly to this methodology four categories of confidence in the 
assessment are described:  I - The interaction has been shown to be relevant to 
human health effects and the direction of the interaction is unequivocal; II - The 
direction of the interaction has been demonstrated in vivo in an appropriate 
animal model and relevance to potential human health effects is likely; III - An 
interaction in a particular direction is plausible but the evidence supporting the 
interaction and its relevance to human health effects is weak; IV - The 
information in this case is A. Insufficient to determine the direction of any 
potential interaction, B. Insufficient to determine whether any interaction would 
occur or C. Adequate as evidence that no toxicological interaction 
between/among the compounds is plausible [8]. 
     For each category, the WOE determination is not intended to consider the 
magnitude of the interaction, the dose levels at which the interaction will occur, 
or the relative amounts of the agents in the mixture. 
     As described previously, the first category is intended to reflect essentially 
complete confidence that the interaction will occur in humans and, therefore, that 
interaction is assumed relevant to human health. However, a classification of 
Category I does not necessarily imply that the interaction has been observed in 
humans, or even that the interaction has been demonstrated in vivo. Despite this 
situation might often be the case, it is not strictly necessary. Nevertheless, the 
classification does indicate that the direction of the interaction can be predicted 
with confidence, and the nature of the interaction has clear toxicological 
relevance for humans [8]. 
     Undesirable substances can occur in food (for example as an inherent natural 
constituent in the food plant or as a contaminant through their presence in the 
environment, through fungal contamination or through preparation processes) 
[6]. 
     As secondary metabolites of toxigenic moulds, mycotoxins can represent a 
great risk for human health. These metabolites can contaminate the ingredients of 
animal feed and human food. In addition to general toxicity, their biological 
effects include also immunosuppressive, estrogenic and genotoxic effects.  
     Although toxicological, environmental and epidemiological studies have 
addressed the problem of these toxins one by one, more than one mycotoxin are 
found usually in the same contaminated food. 
     Aflatoxin B1 and ochratoxin A belong to the most frequently occurring 
mycotoxins. This has repeatedly been demonstrated but the risk resulting from 
their simultaneous occurrence could not be assessed due to the lack of 
information about their combined biological effects [9].  
     Aflatoxins are known to be human carcinogens based on sufficient evidence 
of carcinogenicity in humans. Early evidence for the carcinogenicity of 
aflatoxins in humans came from descriptive studies that correlated geographic 
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variation in aflatoxin content of foods with geographic variation in the incidence 
of liver cancer (hepatocellular carcinoma, or primary liver-cell cancer). Human 
dietary exposure to aflatoxins at levels of nanograms to micrograms per day 
occurs mainly through consumption of a wide variety of contaminated crops like 
maize, groundnuts, cottonseed, soybeans, sorghum, rice and wheat [10].  
     In particularly, Aflatoxin B1 is one of the most deeply studied mycotoxins 
known for a long time that belongs to the group of toxins produced by the genus 
Aspergillus (A. flavus, A. parasiticus, A. nominus) [9, 11–13]. Aflatoxin B1 has 
been classified as a known human carcinogen by the International Agency for 
Research on Cancer [10]. 
     Many authors described its hepatotoxic and hepatocarcinogenic effects in 
laboratory rats, mice, pigs, monkeys, ducks, trout and other animals [9, 14].  
     The metabolic transformation of aflatoxin B1 plays an important role in 
cellular activity. The most important of the metabolites, 8,9-epoxide aflatoxin 
B1, is formed in the organism by oxidation of cytochrome P450 monooxidases. 
It forms adducts with DNA and has a marked mutagenic activity confirmed by 
many tests carried out both in vitro and in vivo [9, 14, 15].  
     Ochratoxin A is the metabolite of some mould species of the genera 
Aspergillus (A. ochraceus, A. sulphurous and others) and Penicillium, especially 
P. viridicatum [16, 17]. These species of moulds grow on stored cereals, wine 
grapes, coffee beans, etc., and, therefore ochratoxin A can be found in a variety 
of food and feed and it is nearly impossible to avoid the daily exposure [17]. 
     It is a strong nephrotoxin causing nephropathies in different species of 
monogastric animals, but many authors also described its hepatotoxic, 
teratogenic, carcinogenic and immunosuppressive effects [17–19]. Ochratoxin A 
inhibits proteosynthesis, mitochondrial respiration and ATP formation and 
increases lipid peroxidation and formation of free radicals [20, 21]. As a possible 
carcinogen for humans, the toxin was classified as 2B cancer compound [22, 23].  
     Many papers have deal with the effect of individual toxins, but the 
interactions between mould metabolites have been reported very rarely [9, 24, 
25].  
     In this paper we presented a mycotoxins mixture case and tried to understand 
what type of interaction can occur and their potential effect on human health. 
2 Materials and methods 
A descriptive study was developed to monitor air fungal contamination in 10 
hospital food units. Five air samples of 250 litres through impaction method 
were collected in food storage facilities, kitchen, food plating, canteen and, also 
outside premises, since this is the place regarded as reference. Considering the 
obtained data, we try to know toxicological relevance of the potential existence 
of a mycotoxins mixture in food by the employ of WOE determination. 
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3 Results and discussion 
Besides other fungal species, in one of the analyzed food units, Aspergillus 
flavus and Aspergillus ochraceus were isolated and, although some strains don’t 
produce mycotoxins, the presence of a mixture was considered. WOE 
determination was applied to qualitative assess the weight of evidence for the 
interaction between aflatoxin B1 and ochratoxin A. 
     Taking into consideration the categories proposed by WOE determination it is 
possible to conclude that Category II is applied in this interaction and potential 
human health effects is likely to occur. The selection of this category was based 
in the ability of ochratoxin A to increase the mutagenic effect of aflatoxin B1. 
This interaction was demonstrated in an animal model (Ames Test) in a study 
developed in 2001 by Sedmíková and colleagues [9]. Those results showed that 
the ability of ochratoxin A to increase the mutagenic effect of aflatoxin B1 may 
be due to the relation of these two toxins to proteosynthesis [9, 26].  
     Humans are most often simultaneously exposed to a large number of 
chemicals from different sources, and we have to take into account that 
combined exposures to low doses of substances that individually do not produce 
any adverse health effects, could still induce toxic effects when they co-occur or 
appear in mixtures. 
     Predicting risk from exposure to chemical mixtures is complex, as chemicals 
in mixtures can interact in terms of both toxicokinetics and toxicodynamics.  
     In the presented case, one important additional factor have to be considered, 
namely the setting where the study was performed involves higher risk because 
occupants vulnerability due to disease.  
     There is availability of a range of intervention approaches that permits 
prevent the adverse health effects of these common food contaminants. In this 
case, exposure can be avoided promoting the tight control of the food products, 
probably the major contamination sources. 
4 Conclusions 
Actually, limits for mycotoxins human exposure only consider the effects of 
each toxin and do not take into consideration their combined effects. It is 
therefore necessary to revise it considering their possible toxicological 
interaction and, to permit performing more accurate health risk assessments. 
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